Kabra Drugs Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Kabra Drugs Ltd. on BSE

Search Inside the pdf :

Kabra Drugs Ltd.

07 Aug 2025, 05:58PM

20.55

4.37%

Board Meeting

Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Intimation Of Board Meeting

BSE India

Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Intimation of Board Meeting

pdf

Kabra Drugs Ltd.

06 Aug 2025

20.55

4.37%

Board Meeting

Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of The Board Meeting And …

BSE India

Outcome of the Board Meeting and disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

pdf

Kabra Drugs Ltd.

31 Jul 2025

20.55

4.37%

Board Meeting

Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Board Meeting

BSE India

Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 ,inter alia, to consider and approve Board Meeting on 6 August 2025

pdf

Kabra Drugs Ltd.

07 Jul 2025, 08:08PM

20.55

4.37%

Company Update

Kabra Drugs Ltd - 524322 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliances - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

pdf

Kabra Drugs Ltd.

30 Jun 2025

20.55

4.37%

SAST

Kabra Drugs Ltd - 524322 - Closure of Trading Window

BSE India

Closure of Trading Window

pdf

Kabra Drugs Ltd.

18 Jun 2025

20.55

4.37%

Board Meeting

Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of The Board Meeting And …

BSE India

Outcome of the Board Meeting and disclosure under Regulation 30 of SEBI(Listing Obligations & Disclosure Requirements) Regulations, 2015

pdf

Kabra Drugs Ltd.

09 Jun 2025, 11:30AM

20.55

4.37%

Board Meeting

Kabra Drugs Ltd - 524322 - Board Meeting Intimation for Intimation Of Proposed Board Meeting Of …

BSE India

Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2025 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, June 18, 2025 at 5:00 PM in Company''s Chennai Office to take on record the following matter: 1. New acquisition 2. New drug license for a Chennai office 3. Diversification by creating new subsidiary 4. Any other agenda with the permission of the chair

pdf